The Controversy Surrounding Transvaginal Mesh: Complications, Lawsuits, and Regulatory Responses

Transvaginal mesh is a medical device used in the treatment of certain pelvic floor disorders in women. These include stress urinary incontinence (SUI) and pelvic organ prolapse (POP).

It is a surgically placed synthetic implant in the vagina to provide support and reinforce weakened or damaged tissues. The mesh is designed to help alleviate symptoms by providing additional structural support to the pelvic organs.

Nevertheless, concerns over its safety and effectiveness have led to increased scrutiny and regulatory actions in recent times. 

However, transvaginal mesh has garnered significant attention and controversy due to reports of complications and adverse effects experienced by some patients. This has resulted in the formation of the vaginal mesh lawsuit. 

Thousands of injured women have filed lawsuits against the manufacturers. Let us look into the troublesome nature of this implant and the actions that have been taken against it through this article.

The Complicated Nature of Implant  

The implant is a net-like structure that provides support for the weakened tissues to grow. The hole on the body of this synthetic mesh allows the tissues to grow into the mesh itself. 

The primary problem may start here itself. One may never be able to remove it from the body. It intends to be permanently placed in case complications arise.   

Other than this, many women have experienced severe complications after transvaginal mesh implants. Some have experienced it years later and some immediately after the operation. A few of them include:

• Discomfort and pain
• Pelvic pain
• Swelling
• Uncomfortable sex
• Infection in the bladder
• Strong pain in the vagina
• Bowel problems

FDA on The Transvaginal Mesh

The investigation was started back in October 2008 when the Food and Drug Administration warned about its serious complications. It was a public health notification about the product released by the FDA.

Later in July 2011, a safety warning was issued, stating that circumstances had changed and major consequences were deemed “not rare.” 

As difficulties persisted, the FDA reclassified vaginal meshes in 2016, requiring permission before they could be promoted for sale. This forced all manufacturers to stop the marketing of vaginal meshes.

Finally, in 2019, the FDA banned two out of three manufacturers of vaginal mesh implants. They had been directed to stop selling and distributing the products immediately. However, numerous vaginal mesh lawsuit cases had been filed in the U.S. against the implants by that time.

The Transvaginal Mesh Lawsuit

According to TorHoerman Law, there have been over 1,00,000 lawsuits filed against transvaginal mesh implants. It alleges that implants have caused several serious injuries. Additionally, it has provided misleading information regarding the product to its customers. 

However, by July 2022, almost 95% of the claims had been resolved or dropped, with the firms paying $525 million. Looking at the number of complaints, it has become one of the largest mass tort litigation in the history of the U.S.

The settlement amount for the lawsuit ranges from $40,000 to $4,50,000 as of April 2024, as stated by Drugwatch. The settlement amount always depends on various factors, including the seriousness of injuries, age factor, and treatment expenses. 

Looking at these big numbers of lawsuits, many countries have decided to take strict action against the implant. Australia and New Zealand have banned the mesh altogether. Canada has restricted the transvaginal mesh. England has paused all the mesh operations. And the UK has updated the hold on the mesh.

Frequently Asked Questions (FAQs)

What steps have been taken regarding transvaginal mesh regulations?

Regulatory agencies, such as the U.S. Food and Drug Administration (FDA), have taken steps to address the safety concerns associated with transvaginal mesh. In 2019, the FDA ordered manufacturers to stop selling and distributing transvaginal mesh products specifically for the treatment of pelvic organ prolapse.

Are there alternative treatments available for pelvic floor disorders?

Yes, there are alternative treatment options available for pelvic floor disorders. These can include physical therapy, lifestyle changes, pelvic exercises, pessaries (vaginal inserts), and in some cases, traditional surgery without the use of mesh. It is important to consult with a healthcare professional to determine the most appropriate treatment option based on individual circumstances.                           

Are there different types of transvaginal mesh?

Yes, there are various types of transvaginal mesh available. They can differ in terms of design, material composition, and characteristics. Some mesh products are specifically designed for stress urinary incontinence, while others are intended for pelvic organ prolapse. The specific type of mesh used may vary depending on the individual patient’s needs and the surgeon’s preference. 

Are there ongoing studies or research related to transvaginal mesh?

Yes, there is ongoing research and studies related to transvaginal mesh. This includes investigations into the long-term outcomes, complications, and patient-reported outcomes. Researchers are also exploring alternative materials and techniques for pelvic floor disorder treatment to improve patient safety and outcomes.

While transvaginal mesh has provided relief for some women, it is important to acknowledge the potential complications associated with its use. 

Patients considering transvaginal mesh should have thorough discussions with healthcare professionals to understand the potential risks, benefits, and alternative treatment options available.